stella
beta
Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML — Stella
Recruiting
Back to Myelodysplastic Syndromes trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu
View full record on ClinicalTrials.gov